Sequence Medical India Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 0.14 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -24.19%
- Profit Growth -38.20%
- Ebitda -90.13%
- Net Worth 1.67%
- Total Assets -15.67%
About Sequence Medical India
Sequence Medical India Private Limited (SMIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 June 2015 (Nine years and seven months 25 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Kumar and Abhishek Kaushik serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51101UP2015PTC071316
-
Company No.
071316
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jun 2015
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Sequence Medical India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kumar
|
Director | 10-Jun-2015 | Current |
|
Abhishek Kaushik
|
Director | 08-Oct-2022 | Current |
Financial Performance of Sequence Medical India.
Sequence Medical India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 24.19% decrease. The company also saw a substantial fall in profitability, with a 38.2% decrease in profit. The company's net worth moved up by a moderate rise of 1.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sequence Medical India?
In 2020, Sequence Medical India had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vascular Access Solutions Private LimitedManoj Kumar is a mutual person
-
Osilar Technologies Private Limited
Manoj Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sequence Medical India?
Unlock and access historical data on people associated with Sequence Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sequence Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sequence Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
